Cargando…
Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804970/ https://www.ncbi.nlm.nih.gov/pubmed/36596315 http://dx.doi.org/10.1016/j.jinf.2022.12.027 |
| _version_ | 1784862235408990208 |
|---|---|
| author | Cillóniz, Catia Motos, Anna Castañeda, Tatiana Gabarrús, Albert Barbé, Ferran Torres, Antoni |
| author_facet | Cillóniz, Catia Motos, Anna Castañeda, Tatiana Gabarrús, Albert Barbé, Ferran Torres, Antoni |
| author_sort | Cillóniz, Catia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9804970 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98049702023-01-04 Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study Cillóniz, Catia Motos, Anna Castañeda, Tatiana Gabarrús, Albert Barbé, Ferran Torres, Antoni J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-03 2022-12-31 /pmc/articles/PMC9804970/ /pubmed/36596315 http://dx.doi.org/10.1016/j.jinf.2022.12.027 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Cillóniz, Catia Motos, Anna Castañeda, Tatiana Gabarrús, Albert Barbé, Ferran Torres, Antoni Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study |
| title | Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study |
| title_full | Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study |
| title_fullStr | Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study |
| title_full_unstemmed | Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study |
| title_short | Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study |
| title_sort | remdesivir and survival outcomes in critically ill patients with covid-19: a multicentre observational cohort study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804970/ https://www.ncbi.nlm.nih.gov/pubmed/36596315 http://dx.doi.org/10.1016/j.jinf.2022.12.027 |
| work_keys_str_mv | AT cillonizcatia remdesivirandsurvivaloutcomesincriticallyillpatientswithcovid19amulticentreobservationalcohortstudy AT motosanna remdesivirandsurvivaloutcomesincriticallyillpatientswithcovid19amulticentreobservationalcohortstudy AT castanedatatiana remdesivirandsurvivaloutcomesincriticallyillpatientswithcovid19amulticentreobservationalcohortstudy AT gabarrusalbert remdesivirandsurvivaloutcomesincriticallyillpatientswithcovid19amulticentreobservationalcohortstudy AT barbeferran remdesivirandsurvivaloutcomesincriticallyillpatientswithcovid19amulticentreobservationalcohortstudy AT torresantoni remdesivirandsurvivaloutcomesincriticallyillpatientswithcovid19amulticentreobservationalcohortstudy AT remdesivirandsurvivaloutcomesincriticallyillpatientswithcovid19amulticentreobservationalcohortstudy |